Securing access for abaloparatide and abaloparatide can be difficult, as they are specialty drugs primarily prescribed for osteoporosis care in individuals at increased risk for fractures. Typically, these therapies are not available over-the-top and require a medical authorization. A physician is the best resource for evaluating appropriateness an